Maximal Suppression of the Androgen Axis in Clinically Localized Prostate Cancer (TAPS)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
GlaxoSmithKline
AstraZeneca
Information provided by (Responsible Party):
Bruce Montgomery, University of Washington
ClinicalTrials.gov Identifier:
NCT00298155
First received: February 27, 2006
Last updated: January 6, 2012
Last verified: January 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: February 2012
  Primary Completion Date: June 2010 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):